scholarly journals Recombinant interferon alpha 2b for ocular surface squamous neoplasia: An efficient and cost-effective treatment modality in Asian Indian patients

2016 ◽  
Vol 64 (10) ◽  
pp. 702 ◽  
Author(s):  
Swathi Kaliki ◽  
Swati Singh ◽  
Sadiya Iram ◽  
Dharani Tripuraneni
Keyword(s):  
Asian Indian ◽  
Ocular Surface ◽  
Treatment Modality ◽  
Cost Effective ◽  
Ocular Surface Squamous Neoplasia ◽  
Recombinant Interferon ◽  
Interferon Alpha 2B ◽  
Effective Treatment Modality ◽  
Cost Effective Treatment ◽  
Recombinant Interferon Alpha

scholarly journals Recombinant interferon Alpha-2b as primary treatment for ocular surface squamous neoplasia

2021 ◽  
Vol 33 (3) ◽  
pp. 260
Author(s):  
Mehran Zarei-Ghanavati ◽  
Reza Ghaffari ◽  
Sahar Barijani ◽  
Arash Alivand ◽  
Golshan Latifi ◽  
...  
Keyword(s):  
Interferon Alpha ◽  
Ocular Surface ◽  
Primary Treatment ◽  
Ocular Surface Squamous Neoplasia ◽  
Recombinant Interferon ◽  
Interferon Alpha 2B ◽  
Recombinant Interferon Alpha

Management of dental fluorosis by amodified treatment strategy amidst a global pandemic

2020 ◽  
Vol 12 (2) ◽  
pp. 46-49
Author(s):  
Dr Nileena Mary Cherian ◽  
Dr K. C Ponnappa ◽  
Dr SalinNanjappa ◽  
Dr K. K Nanjamma
Keyword(s):  
Case Report ◽  
Treatment Strategy ◽  
Treatment Modality ◽  
Dental Treatment ◽  
Dental Fluorosis ◽  
Cost Effective ◽  
Treatment Scenario ◽  
Global Pandemic ◽  
Effective Treatment Modality ◽  
Cost Effective Treatment

In recent months, the dental treatment scenario has changed due to the outbreak of the Covid 19 pandemic. Most of the aerosol generating procedures have been avoided. This case report, describes a conservative, less aerosol generating and cost-effective treatment modality, for the immediate aesthetic management of moderate fluorosis using enamel microabrasion technique.

scholarly journals Cost-effective treatment of ocular surface squamous neoplasia for an undocumented and uninsured New York City patient: a case report

2020 ◽  
Vol 14 (1) ◽  
Author(s):  
Norman A. Saffra ◽  
Trisha S. Emborgo ◽  
Codrin E. Iacob ◽  
David S. Kirsch
Keyword(s):  
New York ◽  
New York City ◽  
Effective Treatment ◽  
York City ◽  
Ocular Surface ◽  
Cost Effective ◽  
Surgical Excision ◽  
Ocular Surface Squamous Neoplasia ◽  
Freeze Thaw ◽  
Cost Effective Treatment

Abstract Background New York City has a heterogeneous population with many undocumented and uninsured immigrants from equatorial areas who have a higher incidence of ocular surface squamous neoplasia. To the best of our knowledge, this is the first documented selection of this cost-effective treatment of ocular surface squamous neoplasia (the use of absolute ethanol along the corneal margin, primary excision, double freeze-thaw cryopexy, and primary conjunctival closure) for an undocumented and uninsured New York City patient. Case presentation A 35-year-old man from Ecuador presented to a New York City emergency department due to worsening discomfort of a long-standing left eye pterygium. A slit-lamp examination of the left eye demonstrated a nasally located conjunctival mass measuring 6 × 8 mm extending onto the cornea (3 mm superiorly and 6 mm inferiorly on the cornea). Histological diagnosis confirmed squamous cell carcinoma in situ arising from the pterygium. Surgical excision with adjunctive absolute alcohol with additive double freeze-thaw cryopexy was performed. Our patient has remained free of tumor recurrence at year 2 postoperative visit. Conclusions Our case highlights the need to choose a cost-effective treatment for ocular surface squamous neoplasia in an at-risk population among undocumented and uninsured patients. Areas in the world with similar types of populations or treatment challenges may need to consider this approach as a primary treatment option.

Long-term treatment with recombinant interferon alpha-2b prolongs survival of asymptomatic HIV-infected individuals

Biotherapy ◽  
1997 ◽  
Vol 10 (2) ◽  
pp. 107-113 ◽  
Author(s):  
J. Rivero ◽  
M. Fraga ◽  
I. Cancio ◽  
J. Cuervo ◽  
P. López-Saura
Keyword(s):  
Interferon Alpha ◽  
Term Treatment ◽  
Recombinant Interferon ◽  
Interferon Alpha 2B ◽  
Long Term Treatment ◽  
Recombinant Interferon Alpha ◽  
Asymptomatic Hiv

The use of combined recombinant interferon alpha-2b medications in the treatment of allergic rhinitis

Vrach ◽  
2021 ◽  
Vol 32 (3) ◽  
pp. 73-81
Author(s):  
D. Trukhan ◽  
V. Alekseenko ◽  
N. Kalashnikova ◽  
V. Minaeva ◽  
O. Shelyapina ◽  
...  
Keyword(s):  
Allergic Rhinitis ◽  
Interferon Alpha ◽  
Recombinant Interferon ◽  
Interferon Alpha 2B ◽  
Recombinant Interferon Alpha
Sign in / Sign up

Export Citation Format

Share Document